Understanding the role of the circadian clock in shaping ECV behavior in cancer contexts is crucial for developing time-sensitive strategies to diagnose, monitor, and treat various malignancies, including HCC, by optimizing treatment efficacy and patient outcomes. Here, CLOCK is linked to hepatocellular carcinoma.